Impact of missense mutations in survival motor neuron protein (SMN1) leading to Spinal Muscular Atrophy (SMA): A computational approach
Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by the mutations in survival motor neuron 1 gene (SMN1). The molecular pathology of missense mutations in SMN1 is not thoroughly investigated so far. Therefore, we collected all missense mutations in the SMN1 protein, using all possible search terms, from three databases (PubMed, PMC and Google Scholar). All missense mutations were subjected to in silico pathogenicity, conservation, and stability analysis tools. We used statistical analysis as a QC measure for validating the specificity and accuracy of these tools. PolyPhen-2 demonstrated the highest specificity and accuracy. While PolyPhen-1 showed the highest sensitivity; overall, PolyPhen2 showed better measures in comparison to other in silico tools. Three mutations (D44V, Y272C, and Y277C) were identified as the most pathogenic and destabilizing. Further, we compared the physiochemical properties of the native and the mutant amino acids and observed loss of H-bonds and aromatic stacking upon the cysteine to tyrosine substitution, which led to the loss of aromatic rings and may reduce protein stability. The three mutations were further subjected to Molecular Dynamics Simulation (MDS) analysis using GROMACS to understand the structural changes. The Y272C and Y277C mutants exhibited maximum deviation pattern from the native protein as compared to D44V mutant. Further MDS analysis predicted changes in the stability that may have been contributed due to the loss of hydrogen bonds as observed in intramolecular hydrogen bond analysis and physiochemical analysis. A loss of function/structural impact was found to be severe in the case of Y272C and Y277C mutants in comparison to D44V mutation. Correlating the results from in silico predictions, physiochemical analysis, and MDS, we were able to observe a loss of stability in all the three mutants. This combinatorial approach could serve as a platform for variant interpretation and drug design for spinal muscular dystrophy resulting from missense mutations.
KeywordsSpinal muscular atrophy Variant classification SMN1 Pathogenicity Stability Molecular dynamic simulation Variant interpretations and classification
The authors acknowledge the management of Vellore Institute of Technology for the seed money and (BRAF) @ CDAC for providing the facilities.
Compliance with ethical standards
Conflict of interest
No potential conflict of interest was reported by the authors.
- Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet Chapter 7:Unit7.20Google Scholar
- Agrahari AK, Muskan M, George Priya Doss C et al (2018b) Computational insights of K1444N substitution in GAP-related domain of NF1 gene associated with neurofibromatosis type 1 disease: A molecular modeling and dynamic approach. Metab Brain Dis. https://doi.org/10.1007/s11011-018-0251-1
- Agrahari AK, Sneha P, George Priya Doss C, Siva R, Zayed H (2017) A profound computational study to prioritize the disease-causing mutations in PRPS1 gene. Metab Brain Dis. https://doi.org/10.1007/s11011-017-0121-2
- Ali SK, Sneha P, Priyadharshini Christy J, Zayed H, George Priya Doss C (2017) Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation. J Biomol Struct Dyn 35(12):2714–2724Google Scholar
- Alías L, Bernal S, Fuentes-Prior P, Barceló MJ, Also E, Martínez-Hernández R, Rodríguez-Alvarez FJ, Martín Y, Aller E, Grau E, Peciña A, Antiñolo G, Galán E, Rosa AL, Fernández-Burriel M, Borrego S, Millán JM, Hernández-Chico C, Baiget M, Tizzano EF (2008) Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene. Hum Genet 125(1):29–39CrossRefPubMedGoogle Scholar
- Briese M, Esmaeili B, Fraboulet S, Burt EC, Christodoulou S, Towers PR, Davies KE, Sattelle DB (2009) Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan. Hum Mol Genet 18:97–104CrossRefPubMedGoogle Scholar
- Finkel RS, Crawford TO, Swoboda KJ, Kaufmann P, Juhasz P, Li X, Guo Y, Li RH, Trachtenberg F, Forrest SJ, Kobayashi DT, Chen KS, Joyce CL, Plasterer T; Pilot Study of Biomarkers for Spinal Muscular Atrophy Trial Group (2012) Candidate Proteins, Metabolites and Transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study. Winkler C, ed. PLoS ONE. 7(4):e35462Google Scholar
- Hess B, Kutzner C, Spoel D van der, Lindahl E (2008) GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation 4(3):435–447. https://doi.org/10.1021/ct700301q
- Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10(6):845–858Google Scholar
- Sneha P, Doss CGP (2017) Chapter Nine - Elucidating the Mutational Landscape in Hepatocyte Nuclear Factor 1β (HNF1B) by Computational Approach. 2017. Chapter Nine - Elucidating the Mutational Landscape in Hepatocyte Nuclear Factor 1β (HNF1B) by Computational Approach. Adv Protein Chem Struct Biol 107:283–306CrossRefPubMedGoogle Scholar
- Sneha P, Ebrahimi EA, Ghazala SA, Thirumal Kumar D, Siva R, George Priya Doss C, Zayed H (2018) Structural Analysis Of Missense Mutations In Galactokinase (Galk1) Leading To Galactosemia Type-2. J Cell Biochem. https://doi.org/10.1002/jcb.27097
- Sneha P, George Priya Doss C (2016) Chapter Seven – Molecular Dynamics: New Frontier in Personalized Medicine. In: Advances in Protein Chemistry and Structural Biology. pp 181–224Google Scholar
- Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, Flynn K, Hendrickson BC, Scholl T, Sirko-Osadsa DA, Allitto BA (2012) Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of 472 400 specimens. Eur J Hum Genet 20:27–32CrossRefPubMedGoogle Scholar
- Zaki OK, George Priya Doss C, Ali SA, Murad GG, Elashi SA, Ebnou MSA, Kumar DT, Khalifa O, Gamal R, El Abd HSA, Nasr BN, Zayed H (2017) Genotype-phenotype correlation in patients with isovaleric acidaemia: comparative structural modelling and computational analysis of novel variants. Hum Mol Genet 26:3105–3115PubMedGoogle Scholar